We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
+6.97%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$17.9B
AUM Growth
+$3.18B
(+22%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
721
New
293
Increased
98
Reduced
124
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$124M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$95.2M |
| 3 |
Pliant Therapeutics
PLRX
|
+$74.8M |
| 4 |
Microsoft
MSFT
|
+$72.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$56.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$123M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$60.4M |
| 3 |
Emerson Electric
EMR
|
+$55M |
| 4 |
Home Depot
HD
|
+$54.8M |
| 5 |
Comcast
CMCSA
|
+$53.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.44% |
| 2 | Technology | 2.51% |
| 3 | Communication Services | 1.69% |
| 4 | Utilities | 1.38% |
| 5 | Industrials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Nkarta
NKTX
$172M
| $2.62M | 0.01% |
1,197,060
| – | – |
|
302
CALL
Las Vegas Sands
LVS
$29.6B
| $2.58M | 0.01% |
+44,400
| New | +$2.63M |
|
303
CALL
MetLife
MET
$62.1B
| $2.5M | 0.01% |
+44,300
| New | +$2.46M |
|
304
Vaxcyte
PCVX
$8.64B
| $2.5M | 0.01% |
+50,000
| New | +$2.37M |
|
305
MeiraGTx Holdings
MGTX
$1.21B
| $2.47M | 0.01% |
+367,937
| New | +$2.37M |
|
306
Builders FirstSource
BLDR
$8.04B
| $2.46M | 0.01% |
+18,089
| New | +$2.01M |
|
307
State Street SPDR S&P Homebuilders ETF
XHB
$1.62B
| $2.46M | 0.01% |
+30,600
| New | +$2.19M |
|
308
Viking Therapeutics
VKTX
$4B
| $2.45M | 0.01% |
151,276
-1,546,076
| -91% | -$32.4M |
|
|
CBAY
309
DELISTED
Cymabay Therapeutics
CBAY
| $2.35M | 0.01% |
214,356
-1,707,747
| -89% | -$15.9M |
|
310
O'Reilly Automotive
ORLY
$76.3B
| $2.32M | 0.01% |
+36,495
| New | +$2.23M |
|
311
PUT
United Airlines
UAL
$42.1B
| $2.22M | 0.01% |
+40,500
| New | +$1.91M |
|
312
CALL
Chipotle Mexican Grill
CMG
$41.5B
| $2.14M | 0.01% |
+50,000
| New | +$1.98M |
|
313
Extra Space Storage
EXR
$31.6B
| $2.08M | 0.01% |
+14,000
| New | +$2.11M |
|
314
CytomX Therapeutics
CTMX
$754M
| $2.04M | 0.01% |
1,188,225
| – | – |
|
315
CALL
Wynn Resorts
WYNN
$10.6B
| $2.03M | 0.01% |
+19,200
| New | +$2.06M |
|
316
Hershey
HSY
$36.6B
| $1.97M | 0.01% |
+7,886
| New | +$2.07M |
|
317
LPL Financial
LPLA
$28.6B
| $1.93M | 0.01% |
8,887
+3,957
| +80% | +$792K |
|
318
PUT
HCA Healthcare
HCA
$89.5B
| $1.91M | 0.01% |
+6,300
| New | +$1.75M |
|
319
CALL
Devon Energy
DVN
$47.3B
| $1.91M | 0.01% |
39,500
+36,300
| +1,134% | +$1.83M |
|
|
320
Chipotle Mexican Grill
CMG
$41.5B
| $1.89M | 0.01% |
+44,150
| New | +$1.75M |
|
321
CSX Corp
CSX
$93.1B
| $1.78M | 0.01% |
+52,103
| New | +$1.65M |
|
322
Marriott International
MAR
$92.3B
| $1.71M | 0.01% |
+9,330
| New | +$1.62M |
|
|
SCPH
323
DELISTED
scPharmaceuticals
SCPH
| $1.68M | 0.01% |
165,000
| – | – |
|
|
THRX
324
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.68M | 0.01% |
179,619
| – | – |
|
325
Coca-Cola
KO
$375B
| $1.67M | 0.01% |
+27,730
| New | +$1.73M |
|
Similar funds
AFM
GCP
LCM
MAP
MA
LFM
NSAM
ABI
Laurion Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Laurion Capital Management held 721 positions worth $17.9B, up 22% from $14.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Laurion Capital Management deployed $2.11B of net new capital in Q2 2023, opening 293 new positions and adding to 98 existing holdings. Its largest new stake was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 6.6% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Viatris, an estimated $123M trimmed.
- Laurion Capital Management's largest Q2 2023 buy was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
- Laurion Capital Management added most to T-Mobile US in Q2 2023, an estimated $124M increase.
- Laurion Capital Management's biggest Q2 2023 reduction was Viatris, cutting an estimated $123M.
- Laurion Capital Management fully exited CATALENT, INC. in Q2 2023, selling an estimated $60.4M.
- Laurion Capital Management's ten largest holdings make up 38% of its $17.9B portfolio in Q2 2023.
- Laurion Capital Management opened 293 new positions and closed 140 in Q2 2023.
- Laurion Capital Management's portfolio value rose 22% quarter-over-quarter to $17.9B.
Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.